Iconovo Accelerator Program is a structured approach for pharmaceutical companies to obtain non-dilutive funding of commercially attractive projects. Iconovo has established a qualified process for applications and implementation of development projects of novel pharmaceuticals.
This is made possible through a newly established collaboration with the consulting firm Argentum, which specializes in structuring and managing application processes for EU funding and has so far helped secure over SEK 20 billion in research and development funding for its clients.
There are substantial grants awarded from the EU every year for innovations in life science, and Iconovo has the expertise and experience to optimize the benefits from them. Iconovo is willing to be a part in application consortiums in commercially interesting projects.
For more information contact Måns Österberg
Press release 230601 about Iconovo Accelerator Program here
Article in BioStock here
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
Ideon, Delta 6 Lund
SE-223 70 LUND